Grifols’ Post

We are pleased to announce that Dr. Tessa Schneeberger , from Philipps-University of Marburg/Schön Klinik Berchtesgadener Land (Germany) received the 2024 ALTA Award from Dr. Marion Trautmann, Grifols’ Global Medical Affairs in Pulmonogy, during the annual congress ERS Congress 2024 held in Vienna.  The also awarded Dr. Benoit Allard from Université de La Réunion (France), who could not attend the congress, will receive the award at a later date.     Founded in 2004 the ALTA Awards support annually independent research by young investigators to shape the future of AATD therapy.    The deadline for submitting nominations for the 2025 ALTA Award starts September 15ht, 2025.  More information here 👉 http://spr.ly/6043iOSST #pulmonology #geneticcopd #GrifolsScientificAwards

We believe that creating learning opportunities for the youth is key to ensuring a more diverse, equal and better future for society. We promote #STEM education programs across America and other countries with a special focus on girls, minorities and disadvantaged communities. In the last year: 🔬 17,000+ girls and boys benefited from our STEM educational programs, 🎓 $50,000+ in scholarships were made available for medical studies. The goal: Do more and do better to contribute to the health and quality of life of people around the world. #DiversityandInclusion #GrifolsSocialIniciatives

For the sixth consecutive year, our manufacturing site in Clayton, N.C. has been validated by Underwriters Laboratory UL Solutions as a “Zero Waste to Landfill” site. We are excited to maintain Gold-level validation for diverting from landfills 97% of the site’s waste, with 6% processing with Energy Recovery, by using recycling, composting, anaerobic digestion and other recovery techniques. ♻️ Effective waste management is part of our circular economy strategy, which includes seeking ways to reduce waste and pollution, as well as prolonging the useful life of materials. #environment #zerowastetolandfill #sustainability

As we continue to celebrate the 50th anniversary of our Clayton facility, today we bring you a story of family and commitment. This fifty-year success story would never have been possible without each and every person who has contributed with passion and determination, and who has brought the best of themselves to our facility. Our Clayton biopharma campus is one of the largest plasma fractionation plants in the world. Its 24/7/365 operation requires a dedicated, committed and exceptional team of employees, like the Medlin family. Their story started 35 years ago, when an 18-year-old Johnston Community College student entered the pooling area. #Biopharma #GrifolsClayton #WeAreHealthcare

Product safety for patients, donor safety and employee safety are our priorities. Our vertically integrated production process guarantees the highest standards of quality and safety, from donation to delivery of plasma-derived medicines to patients. We are very proud of our dedicated quality control team that oversees more than 390 plasma donation centers worldwide. Our rigorous standards are why healthcare professionals trust Grifols products and services. #GrifolsPlasma #GrifolsTeam

Diving into Grifols legacy, we're proud to share a remarkable chapter from our history that continues to inspire us. The pioneering work of Dr. Josep Antoni Grífols i Lucas in 1951 on plasmapheresis marked a turning point in medical science and the plasma industry. His dedication and innovative approach led to a landmark study involving over 350 donors, proving the safety ofthe procedure on donors. The findings presented at an international congress of transfusion medicine and published in the British Medical Journal the next year have been instrumental. It enabled the collection of plasma on a larger scale, offering the scientific community a technique that continues to be the most widespread method for obtaining plasma for the industrial fractionation process to the present day. His legacy continues to inspire us at Grifols as we forge ahead, innovating for patients. Learn more about our history of innovation 👉 http://spr.ly/6048c1YU0

On World Humanitarian Day, we honor the dedication of healthcare workers, volunteers, and aid workers worldwide. Their tireless efforts in the face of adversity inspire us at Grifols. We're proud to support global humanitarian initiatives through partnerships with Direct Relief, and the Red Cross and Red Crescent Movement, bringing aid this year to communities from Brazil's Rio Grande do Sul to the Israel/Gaza region. In times of crisis, the continuity of medical treatments is critical. We are committed to ensuring that those in need receive our essential medicines. Through Direct Relief, our donations have reached patients in Gaza, Ukraine and Cuba. Join us in celebrating these heroes and supporting our shared mission of humanitarian aid. #ActForHumanity #WorldHumanitarianDay #GrifolsSocialImpact

Today, we take you behind the scenes of our factory in Parets del Vallès, Spain, where we manufacture essential plasma-derived medicines. Taking us on this journey is Paula Segura, a manufacturing operator, who started at Grifols as a trainee and earned her first contract in the industry. Our people change lives while growing and developing into a forward-looking international company. #GrifolsTeam

Safety and quality are our priorities. Our vertically integrated production process guarantees the highest standards, from donation to delivery of the plasma-derived medicine to the patient. Grifols plasma centers are licensed and regulated by the U.S. FDA and other international agencies, and they are routinely inspected and certified by the International Quality Plasma Program (IQPP). In addition, we have one of the most innovative traceability systems, PediGri®, which enables healthcare professionals to see extensive manufacturing information at any time on the specific medicines they are administering to patients. It all starts at our donation centers. 👇 #GrifolsPlasma #PlasmaSourceOfLife

This month we celebrate 10 years of business activity in Honk Kong, a decade of dedication, growth, and excellence in supporting our Diagnostics division . Our Hong Kong team has been instrumental in establishing the APAC Financial Shared Service (APAC FSS) and fortifying compliance within the region. Their unwavering commitment has not only enhanced our operations but also solidified our presence in APAC. 🎉 祝賀香港團隊在過去十年所取得的成就，未來必將繼續成功！ #GrifolsHongKong #WeAreHealthcare